Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01754506 · ClinicalTrials.gov registry record · NA
Testing Fish Oil Derivatives In Healing Of Chronic Venous Leg Ulcers
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT01754506: Completed NA study, sponsored by Ohio State University.
NCT01754506 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01754506, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to test the efficacy of an oral, nutrient intervention containing the bioactive components of fish oil to promote healing of chronic venous leg ulcers (CVLU). If this systemic, nutrient intervention is found to alter the microenvironment of CVLU, the science of wound healing and care of patients with CVLU will be vastly improved.
Interventions
- DIETARY_SUPPLEMENT Fish Oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2013-01 |
| Est. Completion | 2015-07 |
| Phase | NA |
What the finished NCT01754506 record still lists
NCT01754506 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Fish Oil is the first listed.
NCT01754506 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01754506 about?
NCT01754506 is a clinical study titled "Testing Fish Oil Derivatives In Healing Of Chronic Venous Leg Ulcers". The purpose of this study is to test the efficacy of an oral, nutrient intervention containing the bioactive components of fish oil to promote healing of chronic venous leg ulcers (CVLU). If this systemic, nutrient intervention is found to alter the microenvironment of CVLU, the science of wound hea...
What is the current status of trial NCT01754506?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2013-01. Estimated completion is 2015-07.
What interventions are being tested in trial NCT01754506?
The interventions under investigation include: Fish Oil (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01754506?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01754506's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia